ArticleRheumatology (Oxford, England)2025

Three-year follow-up of canakinumab dose extension in children with colchicine-resistant familial Mediterranean fever: PeRA-RG Experience.

Gülşah Kavrul Kayaalp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.